Stewart Adams — British chemist and co-developer of ibuprofen

Stewart Adams (1923–2019) was a British pharmaceutical chemist who led the development of ibuprofen, a widely used nonsteroidal anti-inflammatory drug. He worked in Nottingham and was awarded an OBE.

Overview

Stewart Sanders Adams OBE (1923–30 January 2019) was a British pharmaceutical chemist best known for leading the research that produced the pain-relieving drug ibuprofen. His work began in the early 1960s and resulted in one of the most widely used nonsteroidal anti-inflammatory drugs (NSAIDs), valued for treating pain, fever and inflammation.

Career and discovery

Adams carried out his research while working in the pharmaceutical industry in Nottingham. He and his colleagues sought alternatives to existing anti-inflammatory medicines that had serious side effects. Through systematic chemical synthesis and biological testing they identified a propionic acid derivative that combined analgesic and anti-inflammatory effects with a more favourable safety profile for many patients. That compound became known commercially as ibuprofen.

Impact and uses

Ibuprofen established itself as a standard treatment for conditions such as headache, muscle pain, toothache, menstrual cramps, and inflammatory disorders. Over time it moved from prescription use to over-the-counter availability in many countries, expanding access to effective symptomatic relief. The drug is commonly categorized with other NSAIDs and is studied for both its benefits and its risks, such as effects on the stomach and cardiovascular system when used long term.

Notable facts and recognition

Adams was honoured with an OBE for his contributions to medicine and pharmaceutical science.
His discovery is an example of industry-led drug research that generated a broadly used therapeutic agent.
Ibuprofen is often cited in discussions of pain management and the development of safer anti-inflammatory medications.

Death

Stewart Adams died on 30 January 2019 at the age of 95 at the Queen's Medical Centre in Nottingham. His death was attributed to pneumonia, and reports noted the location of his passing at the Queen's Medical Centre in Nottingham. He is remembered for a modest but lasting contribution to public health through the development of an accessible analgesic.